The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group Is BPC 157 Legal? Understanding Its Status and Implications BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification